A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Clinical trial NCT00087711 · COMPLETED

Trial details

NCT number: NCT00087711
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non Small Cell Lung Carcinoma

Start date: 2004-07-01
Primary completion: 2007-01-01
Enrollment: 1713

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.